T. Rowe Price Associates
BMEA icon

T. Rowe Price Associates’s Biomea Fusion BMEA Stock Holding History

T. Rowe Price Associates’s Portfolio BMEA Stock Details BMEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,352
Closed -$42K – 3073
2025
Q1 		$42K Hold
19,352
– – ﹤0.01% 2950
2024
Q4 		$76K Buy
19,352
+1,215
+7% +$9.68K ﹤0.01% 2882
2024
Q3 		$184K Buy
18,137
+3,600
+25% +$23.4K ﹤0.01% 2679
2024
Q2 		$66K Sell
14,537
-163,065
-92% -$1.66M ﹤0.01% 2818
2024
Q1 		$2.66M Buy
177,602
+1,028
+0.6% +$16.9K ﹤0.01% 1442
2023
Q4 		$2.56M Buy
176,574
+34,138
+24% +$415K ﹤0.01% 1423
2023
Q3 		$1.96M Sell
142,436
-86,814
-38% -$1.57M ﹤0.01% 1470
2023
Q2 		$5.03M Buy
+229,250
New +$7.18M ﹤0.01% 1186

Other funds holding BMEA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates's BMEA Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Biomea Fusion (BMEA) in Q2 2025, closing a stake of 19,352 shares — an estimated $42K sold.

T. Rowe Price Associates first reported a position in BMEA in Q2 2023 and held it in 8 quarters. The position peaked at $5.03M in Q2 2023. 87 funds tracked by Wall St. Rank hold BMEA as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Biomea Fusion position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 19,352 Biomea Fusion shares in Q2 2025, an estimated $42K.
  • T. Rowe Price Associates first reported a position in Biomea Fusion in Q2 2023 and held it in 8 quarters.
  • T. Rowe Price Associates's Biomea Fusion position peaked at $5.03M in Q2 2023.
  • 87 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.